Skip to content
Recall Observatory FDA recall evidence

Drug product

WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tablets, NDC 64727-5650-4; c) 60 Tablets, NDC 64727-5650-5; d) 90 Tablets, NDC 64727-5650-6; e) 100 Tablets, NDC 64727-5650-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

D-1608-2020

August 25, 2020

Class II

Product summary

Firm
RLC Labs Inc.
Event
Event 86343
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-1608-2020

Official wording

Reason: CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Code information: All lots with expiry between 10/2020-07/2023

Distribution pattern: Nationwide in the United States

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations
  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    subpotent